Strategies for Enhancing Non-small Cell Lung Cancer Treatment: Integrating Chinese Herbal Medicines with Epidermal Growth Factor Receptor-Tyrosine Kinase …
L Chen, WD Chen, YX Xu, YY Ren, C Zheng… - European Journal of …, 2024 - Elsevier
Non-small cell lung cancer (NSCLC) poses a global health threat, and epidermal growth
factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib, afatinib, and …
factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib, afatinib, and …